A Study on Early Sucking of Lollipops in Preschool Children After Adenotonsillectomy

A Study on Early Sucking of Lollipops in Preschool Children After Adenotonsillectomy:a Randomized Controlled Trial

The aim of this study is to observe the consumption effect of early lollipop sucking in preschool children after adenotonsillectomy through clinical experiments, and to explore the impact of early postoperative lollipop consumption on postoperative agitation, incidence of postoperative nausea and vomiting, and postoperative wound recovery rate.

Participants will be randomly allocated to two groups:a lollipop sucking group (Group A) and a control group (Group B), Two groups of children were sent to the recovery room (PACU) for observation after extubation . Group A patients were given lollipops for sucking after waking up, while Group B received routine nursing treatment.

The goal of this clinical trial is to explore whether lollipops have advantages in early postoperative feeding and alleviating postoperative agitation in children, and to provide reliable clinical evidence for the consumption of lollipops after surgery.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

186

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430000
        • Maternal and Child Health Hospital of Hubei Province

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • patients who choose to have adenotonsillectomy surgery
  • the American Society of Anesthesiologists (ASA) physical status ranked I-II
  • competent to provide informed consent

Exclusion Criteria:

  • psychiatric disorders
  • upper respiratory tract infection
  • high risk of reflux aspiration
  • carbohydrate malabsorption syndrome and other endocrine or genetic metabolic diseases (contraindications of lollipop ingredients)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lollipop group
Lollipop group patients were given lollipops for sucking in the PACU
In the Lollipop group,children were sent to the recovery room (PACU) for observation after extubation after surgery.They were given lollipops for sucking without chewing after waking up.Throughout the entire sucking process, we continuously monitor vital signs.
Active Comparator: Control group
Control group patients were received routine nursing treatment in the PACU.
In the Control group,children were sent to the recovery room (PACU) for observation after extubation after surgery.They were received routine nursing treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative agitation score
Time Frame: Time Frame: intraoperative period,10 minutes-1 hours
Postoperative agitation score will be recorded at 6 time points, including the time of entering the recovery room (Time 0), when the lollipop is given (Time 1), when the lollipop is given for 10 minutes(Time 2), when the lollipop is given for 20 minutes(Time 3), when the lollipop is given for 30 minutes(Time 4) and leave the recovery room (T5).
Time Frame: intraoperative period,10 minutes-1 hours
Incidence of nausea and vomiting
Time Frame: Postoperative 1 minute-5hours
Incidence of nausea and vomiting will be recorded during the time of the recovery room and four hours after returning to the ward .
Postoperative 1 minute-5hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spo2
Time Frame: Postoperative 1 minute - 5hours
Spo2 will be continuous monitoring and recorded during the time of the recovery room
Postoperative 1 minute - 5hours
other adverse reactions
Time Frame: Postoperative 10 minutes - 3days
The occurrence of adverse reactions( wound infection and others) were continuous monitoring and recorded after the operation
Postoperative 10 minutes - 3days
the time of leaving the recovery room and the hospital
Time Frame: Postoperative 1 hour - 3days
the time of leaving the recovery room and the hospital will be recorded
Postoperative 1 hour - 3days
family satisfaction
Time Frame: Postoperative 5 hours
Record the satisfaction of the parents with this operation ,defined as a score out of 100
Postoperative 5 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Na Li, MD, Maternal and Child Health Hospital of Hubei Province

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2024

Primary Completion (Actual)

April 28, 2025

Study Completion (Actual)

April 28, 2025

Study Registration Dates

First Submitted

October 21, 2024

First Submitted That Met QC Criteria

October 26, 2024

First Posted (Actual)

October 29, 2024

Study Record Updates

Last Update Posted (Actual)

June 12, 2025

Last Update Submitted That Met QC Criteria

June 11, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MCHH_006

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adenotonsillectomy

Clinical Trials on Lollipop group

Subscribe